Bladerunner, Here is some information that misspinkard may like if you would want to post it on that cancer patient website to her. First I am long Neoprobe so yes I am a pumper but the Rigs technology works and I believe in it. Here is the survival data that was performed on stage 4 patients. An independent clinical research organization performed a survival analysis based on the patients enrolled in NEO2-14, the pivotal clinical study that served as the primary evidence submitted to the FDA in 1997 as the basis for the Company's Biologic License Application (BLA). Ninety-four of 109 evaluable patients determined by the FDA were available for analysis. The study found the five-year mortality rates for the following:
91% mortality for those patients diagnosed with positive spread of disease without the aid of RIGS (Traditional+) 53% mortality for those patients diagnosed with positive spread of disease with the aid of RIGS positive but were otherwise traditionally negative( RIGS+/traditional-)
25% mortality for those patients who have no evidence of spread of disease with the aid of RIGS (RIGS-/Traditional-) Source: Schneebaum et. al., Budapest 2004
Neoprobe could get a CMA, allows patients to get the surgery while the trials are going on, in Europe as early as Q4 of 2009/Q1-2010 so she may want to keep her eye on this technology if she still has colon cancer. Here is a blog that has more info on Neoprobe and Rigs. http://www.investorvillage.com/blog.asp?b=3A649286B78CB5E9
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.